Temozolomide (TMZ) and radiation therapy (RT) combination in elderly patients with glioblastoma: A multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

被引：0
|
作者：
Lombardi, Giuseppe
Pace, Andrea
Pasqualetti, Francesco
Rizzato, Simona
Faedi, Marina
Anghileri, Elena
Nicolotto, Elisa
Bazzoli, Elena
Bellu, Luisa
Villani, Veronica
Fabi, Alessandra
Ferrazza, Patrizia
Gurrieri, Lorena
Dall'Agata, Monia
Eoli, Marica
Della Puppa, Alessandro
Pambuku, Ardi
D'Avella, Domenico
Ruda, Roberta
Zagonel, Vittorina
机构：
[1] Veneto Inst Oncol IRCCS, Med Oncol 1, Dept Clin & Expt Oncol, Padua, Italy
[2] Regina Elena Inst Canc Res, Neurooncol Unit, Rome, Italy
[3] Azienda Osped Univ Pisana, Dept Radiotherapy, Pisa, Italy
[4] Azienda Osped Univ Udine, Dept Oncol, Udine, Italy
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Meldola, Italy
[6] Fdn IRCCS Ist Neurol C Besta, Unit Mol Neurooncol, Milan, Italy
[7] Univ Turin, Dept Neurooncol, Turin, Italy
[8] City Hlth & Sci, Turin, Italy
[9] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy
[10] Ctr S Giovanni di Dio Fatebenefratelli, IRCCS, Brescia, Italy
[11] Regina Elena Inst Canc Res, Div Med Oncol, Rome, Italy
[12] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Biostat & Clin Trials Unit, Meldola, Italy
[13] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[14] Azienda Osped Padova, Dept Neurosurg, Padua, Italy
[15] Univ Padua, Dept Neurosurg, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e13003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13003
引用
收藏
页数：1
相关论文
共 50 条
  • [21] IDH-wild type low grade gliomas: An AINO (Italian Association of Neuro-Oncology) retrospective study.
    Ruda, Roberta
    Bruno, Francesco
    Silvani, Antonio
    Ius, Tamara
    Bello, Lorenzo
    Minniti, Giuseppe
    Pace, Andrea
    Lombardi, Giuseppe
    Soffietti, Riccardo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] DOSE-DENSE TEMOZOLOMIDE AS INITIAL TREATMENT FOR PROGRESSIVE LOW GRADE OLIGODENDROGLIAL TUMORS: A MULTICENTER PHASE II STUDY OF THE AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY)
    Ruda, R.
    Bertero, L.
    Trevisan, E.
    Pace, A.
    Carapella, C.
    Dealis, C.
    Caroli, M.
    Faedi, M.
    Bomprezzi, C.
    Soffietti, R.
    NEURO-ONCOLOGY, 2012, 14 : 11 - 11
  • [23] Temozolomide (TMZ) for 21/28 days in patients with progressive glioblastoma (GBM): Preliminary results of phase II study of gicno (Italian neuro-oncology group)
    Tosoni, A.
    Cavallo, G.
    Scopece, L.
    Franceschi, E.
    Nicolardi, L.
    Roma, A.
    Blatt, V.
    Gioia, V.
    Crino, L.
    Brandes, A. A.
    ANNALS OF ONCOLOGY, 2005, 16 : 63 - 63
  • [24] Temozolomide (TMZ) for 21/28 days in patients with progressive glioblastoma (GBM):: Preliminary results of phase 2 study of GICNO (Italian Neuro-Oncology Group)
    Brandes, A
    Cavallo, G
    Tosoni, A
    Ermani, M
    Scopece, L
    Franceschi, E
    Nicolardi, L
    Talacchi, A
    Blatt, V
    Crinò, L
    NEURO-ONCOLOGY, 2005, 7 (03) : 312 - 312
  • [25] DOSE DENSE TEMOZOLOMIDE (TMZ) AS INITIAL TREATMENT FOR HIGH-RISK OLIGODENDROGLIAL TUMORS: LONG-TERM RESULTS OF A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY
    Soffietti, Riccardo
    Pellerino, Alessia
    Pace, Andrea
    Carapella, Carmine
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bello, Lorenzo
    Ruda, Roberta
    NEURO-ONCOLOGY, 2017, 19 : 2 - 2
  • [26] TEMOZOLOMIDE (TMZ) 1 WEEK ON/1 WEEK OFF AS INITIAL TREATMENT FOR HIGH RISK LOW GRADE OLIGODENDROGLIAL TUMORS: A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY
    Pellerino, A.
    Franchino, F.
    Pace, A.
    Carapella, C.
    Dealis, C.
    Caroli, M.
    Faedi, M.
    Bomprezzi, C.
    Ruda, R.
    Soffietti, R.
    NEURO-ONCOLOGY, 2017, 19 : 21 - 21
  • [27] IDH-WILD TYPE GRADE II GLIOMAS: A RETROSPECTIVE SERIES OF AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY)
    Bruno, F.
    Silvani, A.
    Ius, T.
    Bello, L.
    Minniti, G.
    Pace, A.
    Lombardi, G.
    Soffietti, R.
    Ruda, R.
    NEURO-ONCOLOGY, 2018, 20 : 220 - 221
  • [28] Predictors of survival in glioblastoma patients treated with fotemustine at first relapse after Stupp regimen: Analysis of GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)
    Lombardi, G.
    Scoccianti, S.
    Fabrini, M. G.
    Santoni, M.
    Villani, V.
    Silvani, A.
    Marinelli, A.
    Lolli, I.
    Balducci, M.
    Arcicasa, M.
    Salvati, M.
    Sponghini, A.
    Vallarelli, S.
    Caroli, M.
    Imbesi, F.
    Bilancia, D.
    Faedi, M.
    Zagonel, V.
    Soffietti, R.
    Ruda, R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S584 - S584
  • [29] A phase II trial of temozolomide (TMZ) 1 week on/1 week off as initial treatment for high risk low grade oligodendroglial tumors: An AINO (Italian Association for Neuro-Oncology) study.
    Ruda, Roberta
    Pellerino, Alessia
    Franchino, Federica
    Pace, Andrea
    Carapella, Carmine Maria
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bomprezzi, Chiara
    Soffietti, Riccardo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] ALTERNATING WEEKLY TEMOZOLOMIDE AS INITIAL TREATMENT FOR PROGRESSIVE LOW-GRADE OLIGODENDROGLIAL TUMORS: A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY
    Soffietti, Riccardo
    Roda, Roberta
    Trevisan, Elisa
    Laguzzi, Elena
    Picco, Elisabetta
    Guarneri, Dainele
    Caroli, Manuela
    Crippa, Flavio
    NEURO-ONCOLOGY, 2008, 10 (05) : 838 - 838
12345